Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 14/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.37 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.37 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.37 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21453641 | 0.88 | HTR6 (0.45) | CYP2C9ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL19846001 | 0.88 | NAMPT (0.40) | NAMPTCYP2C9ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL21454059 | 0.82 | NAMPT (0.42) | NAMPTCYP2C9NAPRTABCC9ABCC8 | |
| SCHEMBL30450889 | 0.81 | HTR6 (0.41) | CYP2C9ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL20689906 | 0.80 | HTT (0.46) | CYP2C9ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL20383146 | 0.78 | PKM (0.40) | CYP2C9ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL21453943 | 0.78 | HTT (0.50) | CYP2C9ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL20689853 | 0.76 | HTT (0.49) | CYP2C9ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL19846029 | 0.76 | HTR6 (0.38) | NAMPTCYP2C9ALDH1A1 | |
| SCHEMBL19846048 | 0.76 | HTR6 (0.38) | NAMPTNAPRTABCC9ABCC8KCNJ11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190312210-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190312210-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLCO4C1, SLCO2A1, SLCO1A2 | NAMPT 3550/4885CYP2C9 729/4885ALDH1A1 569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.